Report no 296/2026
Podstawa prawna: Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieżące i okresowe
Sofia, Bulgaria, October 20, 2026 - "Sopharma" AD (SFA: "Bulgarian Stock Exchange" AD, SPH: Warsaw Stock Exchange) pursuant to the requirements of art. 100t of the Law on Public Offering of Securities (LPOS), hereby informs that in September 2026 the Company reported a 13% increase in sales compared to the same month of the previous year, including a 20% increase in domestic sales and a 8% increase in export sales.
